DRTS.NASDAQAlpha Tau Medical LTD

Form 4: Alpha Tau Medical CFO Sells Shares

Sentiment:

Insider Transaction Report

📋All filings for Alpha Tau Medical LTD
🔒Login to Follow

Alpha Tau Medical Ltd. CFO Raphi Levy reported transactions involving the sale of ordinary shares.

Summary

  • Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported the sale of 15,000 ordinary shares on June 23, 2026, at a price of $9.47 per share.
  • An additional sale of 2,500 ordinary shares occurred on the same date at a price of $10.0004 per share.
  • Following these transactions, Mr. Levy beneficially owns 132,680 ordinary shares directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the CFO selling shares, which can sometimes be interpreted as a lack of confidence or a need for personal liquidity, although the exact reasons are not disclosed.

Negatives

  • The Chief Financial Officer sold a significant number of shares.
  • The sales occurred on June 23, 2026, with prices ranging from $9.47 to $10.0004 per share.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings typically report changes in beneficial ownership by insiders, such as officers and directors. These transactions can sometimes signal insider confidence or a need for liquidity, and are closely watched by investors.

Stakeholder Impact

  • Shareholders may view the CFO's sale of shares with caution, potentially impacting short-term stock sentiment.
  • The transactions do not appear to directly impact employees, customers, suppliers, or creditors based on the information provided.

Key Dates

DateDescription
06/23/2026Date of earliest transaction and sale of ordinary shares.
06/24/2026Deemed execution date for transactions.
06/25/2026Date of report signature.

Recommendation

hold

The filing reports insider sales by the CFO. While this can be a negative signal, the exact number of shares sold relative to total holdings and the absence of other negative news warrant a 'hold' recommendation pending further information or context. A seasoned investor would monitor future filings and company performance closely.

Keywords

Alpha Tau Medical, DRTS, Form 4, Insider Trading, Share Sale, Raphi Levy, Chief Financial Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.